Bear bile: dilemma of traditional medicinal use and animal protection
Tóm tắt
Từ khóa
Tài liệu tham khảo
Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES)[ http://www.cites.org ]
Society of Japanese Pharmacopoeia: The Japanese Pharmacopoeia. Part II. Tokyo. 10th edition. 1981.
Makino I, Takebe K: Bear bile and ursodeoxycholic acid. Sogo Rinsho 1982, 31: 2385-2387.
Jeng WS, Cheng-Low TH: Bear bile resources – past and future. Yu-Lan Chinese Medicine College Bulletin 1992, 15: 27-30.
Gao XM, (Ed): Chinese Materia Medica. Xiongdan. Bejing. China Chinese Medicine Publisher; 2002:160-161.
Kenney JS, Smith JLD, Starfield AM, McDougal CW: Saving the tiger in the wild. Nature 1994, 369: 352. 10.1038/369352a0
Still J: Use of animal products in traditional Chinese medicine: environmental impact and health hazards. Complementary Therapies in Medicine 2003, 11: 118-122. 10.1016/S0965-2299(03)00055-4
Lee YJ: The use of bear bile as medicine versus tonic. In Proceedings of the Third International Symposium on the Trade in Bear Parts: 26–28 October, 1999; Souel, Republic of Korea. Edited by: Douglas F Williamson, Marcus J. Phipps: Traffic East Asia; 1999:122-126.
Pong S, Lo YW, Ho KC: Herbal alternatives to bear bile. In Proceedings of the Third International Symposium on the Trade in Bear Parts: 26–28 October, 1999; Souel, Republic of Korea. Edited by: Douglas F Williamson, Marcus J. Phipps: Traffic East Asia; 1999:154-157.
Sakakura H, Suzuki M, Kimura N, Takeda H, Nagata S, Maeda M: Simultaneous determination of bile acids in rat bile and serum by high-performance liquid chromatography. Journal of Chromatography 1993, 621: 123-131. 10.1016/0378-4347(93)80087-K
Ando M, Kaneko T, Watanabe R, Kikuchi S, Goto T, Iida T, Hishinuma T, Mano N, Goto J: High sensitive analysis of rat serum bile acids by liquid chromatography/electrospray ionization tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 2006, 40: 1179-1186. 10.1016/j.jpba.2005.09.013
Zhang Q, Li S, Cheng J, Yan K, Tian S: HPTLC densitometric determination of free bile acids in bezoar. China Journal of Chinese Materia Medica 1990, 15: 360-362.
Cavrini V, Gatti R, Roda A, Cerrè C, Roveri P: HPLC-fluorescence determination of bile acids in pharmaceuticals and bile after derivatization with 2-bromoacetyl-6-methoxynaphthalene. Journal of Pharmaceutical and Biomedical Analysis 1993, 11: 761-770. 10.1016/0731-7085(93)80186-5
Maruyama K, Tanimura H, Hikasa Y: Analysis of conjugated bile acids in bile by high-pressure liquid chromatography. Clinica Chimica Acta 1980, 100: 47-54. 10.1016/0009-8981(80)90184-9
Nakayama F, Nakagaki M: Quantitative determination of bile acids in bile with reversed-phase high-performance liquid chromatography. Journal of Chromatography 1980, 183: 287-293. 10.1016/S0378-4347(00)81708-9
Tietz PS, Thistle JL, Miller LJ, LaRusso NF: Development and validation of a method for measuring the glycine and taurine conjugates of bile acids in bile by high-performance liquid chromatography. Journal of Chromatography 1984, 336: 249-257. 10.1016/S0378-4347(00)85148-8
Wang FS, Xu LX, Zhao YJ, Liu AR, Jin LZ, Zhang XQ: Determination of bile acids in bear gall drainage by thin layer chromatographic scanning. Acta Pharmaceutica Sinica 1989, 24: 397-400.
Shepherd RW, Bunting PS, Khan M, Hill JG, Soldin SJ, Gall DG: A rapid, sensitive method for accurate analysis of individual bile acids in biological fluids by high performance thin-layer chromatography and densitometry. Clinical Biochemistry 1978, 11: 106-111. 10.1016/S0009-9120(78)90112-1
Zhang YK, Chen N, Zao RH, Li T, Wang ZY, Lu PC: The retention behaviour of conjugated bile acids in reversed phase high performance liquid chromatography. Biomedical Chromatography 1992, 6: 255-257. 10.1002/bmc.1130060512
Roda A, Cerre C, Simoni P, Polimeni C, Vaccari C, Pistillo A: Determination of free and amidated bile acids by high-performance liquid chromatography with evaporative light-scattering mass detection. Journal of Lipid Research 1992, 33: 1393-1402.
Wang LY, Gao X, Tong ZL, Wang XG: Summary on pharmacological action and clinical study of the chemical composition of bear bile. Information on Traditional Chinese Medicine 2005, 22: 30-33.
You YY, Wan DG: Advance in research on medical use of animal bile. Journal of Guiyang College of Traditional Chinese Medicine 2007, 29: 58-61.
Espinoza EO, Shafer JA, Hagey LR: International trade in bear gall bladders: Forensic source inference. Journal of Forensic Sciences 1993, 38: 1363-1371.
Jones JD, Zollman PE: Black bear ( Ursus americanus ) bile composition: Seasonal changes. Comparative Biochemistry and Physiology. Part C, Pharmacology, Toxicology & Endocrinology 1997, 118: 387-390. 10.1016/S0742-8413(97)00176-X
Mukhopadhyay S, Maitra U: Chemisatry and biology of bile acids. Current Science 2004, 87: 1666-1683.
MacDonald AC, Williams CN: Studies of bile lipids and bile acids of wild North American black bears in Nova Scotia, showing a high content of ursodeoxycholic acid. The Journal of Surgical Research 1985, 38: 173-179. 10.1016/0022-4804(85)90024-1
Hagey LH, Crombie DL, Espinosa E, Carey MC, Igimi H, Hofmann AF: Ursodeoxycholic acid in the Ursidae: biliary bile acids of bears, pandas, and related carnivores. Journal of Lipid Research 1993, 34: 1911-1917.
Yang CM, Wang HZ, Hu RL, Feng ZS: Studies on the bile-acid compositions of several fowl and domestic animals bile. Xinjiang Agricultural Sciences 2006, 43: 467-471.
Lin DL, Chang HC, Chang CP, Chen CY: Identification and differentiation of bear bile used in medicinal products in Taiwan. Journal of Forensic Science 1997,42(5):817-823.
Yu SZ: Pharmacological effects and clinical application of Bear bile. Lishizhen Medicine and Materia Medica Research 2007, 18: 707-708.
Liu Y, Guo XM, Li JH: Effects of Tauroursodeoxycholic acid (TUDCA) on Activities of Glutamic Pyruvic Transaminase (GPT). Journal of China Pharmaceutical University 1995,26(4):239-241.
Li JS, Wu ZF, Zhang JB, Xiong CM, Liu YB: Pharmacological studies on the comparison between the Drainage and Certified Fel Ursi. China Journal of Chinese Materia Medica 1991,16(12):749-752.
Quan MJ, Jin RS, Piao L, Piao DM: Inhibitory effects of bear bile powder on dimethylnitrosamine-induced liver fibrosis in rats. World Chinese Journal of Digestology 2005, 13: 2487-2490.
Li WJ, Zhang JQ, Hou F, Wang JM: Pharmacological studies on the comparison between the Drainage and Certified Fel Ursi. Journal of Chinese Medicinal Materials 1990,13(2):12-15.
Sheng L, Zhang ML, Li H: Clinical observation on elimination of chronic hepatitis B induced jaundice in 33 CHB patients after administrated with xiongdan capsule. Journal of Clinical Hepatology 1994, 7: 40-41.
Mills JA: Milking the bear trade. International Wildlife 1992, 22: 38-45.
Cochrane GM: Animals Asia Foundation report, Problems associated with the "Free-dripping fistula technique" as a method of bile extraction from asiatic black bears. Animals Asia Foundation 2003. [ http://www.animalasia.org ]
Loeffler K, Robinson J, Cochrane G: Animals Asia Foundation report, Compromised health and welfare of bears in China's bear bile farming industry, with special reference to the free-dripping bile extraction technique. Animals Asia Foundation 2007. [ http://www.animalasia.org ]
Liang FX, Wen TF, Wu YC: Comparative Determination of the chemical compositions between natural bear bile and drained bear bile. Journal of Jilin Agricultural University 1993, 15: 140-142.
Zhang QM, Yin XJ, Yan KD: HPLC Determination of tauroursodeoxycholic acid and taurochenodeoxycholic acid in bear bile powder. Chinese Journal of Pharmaceutical Analysis 1993, 13: 321-324.
Gong JY, Shi L, Yu P: RP-HPLC determination of ursodeoxycholic acid in bear bile produced in different regions. Journal of Changchun University of Traditional Chinese Medicine 2002, 18: 46.
Xu XZ, Zhang XY, Jin XH: Studies on analysis of tauroursodeoxycholic acid and taurochenodeoxycholic acid in bear biliary drainage powder by HPLC. Journal of Yanbian University (Natural Science) 1999, 25: 90-93.
Zhang Z, Liao G, Song Y, Yin H: Determination of ursodeoxycholic acid and chenodeoxycholic acid in Chinese medicinal compound preparations by TLC-densitometry. China Journal of Chinese Materia Medica 1995, 20: 162-164. 192
Ge Gabriel G: A bitter medicine: the use of bear bile in China. In Proceedings of the Third International Symposium on the Trade in Bear Parts: 26–28 October, 1999; Souel, Republic of Korea. Edited by: Douglas F Williamson, Marcus J. Phipps: Traffic East Asia; 1999:116-120.
Convention World Society for the Protection of Animals (WSPA): From Cage to Consumer. WSPA 2007. [ http://www.wspa-international.org ]
Animals Asia Foundation (AAF): China bear rescue, History, The agreement summary. AAF 2000. [ http://www.animalsasia.org ]
Meng S, Huang HK, Li Z: Bear breeding and conservation of its resource in China. Chinese Journal of Wildlife 2007, 28: 27-32.
Li YW, Zhu XY, But PP, Yeung HW: Ethnopharmacology of bear gall bladder: I. Journal of Ethnopharmacology 1995, 47: 27-31. 10.1016/0378-8741(95)01249-D
Gu XC, Li MD, Chang JQ, Cui GZ: Comparison between pharmacologic actions of rabbit bile and bear bile. China Journal of Chinese Materia Medica 1994, 19: 556-558.
Nette T: Bear gallbladders to sell or not to sell. Wildlife Division, Department of Natural Resources, Nova Scotia, Canada 2000. [ http://www.gov.ns.ca/natr/wildlife/lgmams/beargalls.htm ]
Kaplan MM: The use of methotrexate, colchicine, and other immunomodulatory drugs in the treatment of primary biliary cirrhosis. Seminars in Liver Disease 1997, 17: 129-136. 10.1055/s-2007-1007191
Rubin RA, Kowalski TE, Khandelwal M, Malet PF: Ursodiol for hepatobiliary disorders. Annals of Internal Medicine 1994, 121: 207-218.
The Association of Chinese Medicine and Philosophy and EarthCare, Hong Kong: The herbal alternatives to bear bile in Chinese medicine. Hong Kong. 1994.
Roberts A: A case for a uniform global ban on the trade in bear parts and derivatives (a perspective from the United States). In Proceedings of the Third International Symposium on the Trade in Bear Parts: 26–28 October, 1999; Souel, Republic of Korea. Edited by: Douglas F Williamson, Marcus J. Phipps: Traffic East Asia; 1999:138-152.
Appiah SS, Bremner P, Heinrich M, Kokubun T, Simmonds MSJ, Bell C: Herbal alternatives to bear bile: effects of Scutellaria baicalensis Georgi on IL-6 promoter and CYP3A4 activities. Focus Altern Complement Ther 2006, 11: 03.
Feng Y, Luo WQ, Zhu SQ: Explore new clinical application of Huanglian and corresponding compound prescriptions from their traditional use. China Journal of Chinese Materia Medica 2008, 33: 1221-1225.
Shen JB: Advance of application and research on Huanglian resources. Modern Medicine & Health 2006,22(7):1038-1039.
Chen YX, Gao XS: Huanglian uniquity and Huanglian Method in ancient literature of Chinese Medicine. Chinese Traditional Patent Medicine 1997,19(9):36-37.
Tian ZY, Li ZG: Recent Advance in Huanglian research. Lishizhen Medicine and Materia Medica Research 2004,15(10):704-706.
Chang HM, But PaulPH: Pharmacology and applications of Chinese Materia Medica. World Scientific Publishing, Hong Kong; 2001:1061-1077.
Choi UK, Kim MH, Lee NH: Optimization of antibacterial activity by Gold-Thread (Coptidis Rhizoma Franch) against Streptococcus mutans using evolutionary operation-factorial design technique. Journal of microbiology and biotechnology 2007,17(11):1880-1884.
Kim HY, Shin HS, Park H, Kim YC, Yun YG, Park S, Shin HJ, Kim K: In vitro inhibition of coronavirus replications by the traditionally used medicinal herbal extracts, Cimicifuga rhizoma, Meliae cortex, Coptidis rhizoma, and Phellodendron cortex. Journal of clinical virology 2008, 41: 122-128. 10.1016/j.jcv.2007.10.011
Fukutake M, Yokota S, Kawamura H, Iizuka A, Amagaya S, Fukuda K, Komatsu Y: Inhibitory effect of Coptidis Rhizoma and Scutellariae Radix on azoxymethane-induced aberrant crypt foci formation in rat colon. Biological & pharmaceutical bulletin 1998, 21: 814-817.
Li XK, Motwani M, Tong W, Bornmann W, Schwartz GK: Huanglian, A Chinese herbal extract, inhibits cell growth by suppressing the expression of cyclin B1 and inhibiting CDC2 kinase activity in human cancer cells. Molecular Pharmacology 2000, 58: 1287-1293.
Yokozawa T, Ishida A, Kashiwada Y, Cho EJ, Kim HY, Ikeshiro Y: Coptidis Rhizoma: protective effects against peroxynitrite-induced oxidative damage and elucidation of its active components. Journal of Pharmacy and Pharmacology 2004, 56: 547-556. 10.1211/0022357023024
Yokozawa T, Ishida A, Cho EJ, Nakagawa T: The effects of Coptidis Rhizoma extract on a hypercholesterolemic animal model. Phytomedicine 2003, 10: 17-22. 10.1078/094471103321648610
Sanae F, Komatsu Y, Chisaki K, Kido T, Ishige A, Hayashi H: Effects of San'o-shashin-to and the constituent herbal medicines on theophylline-induced increase in arterial blood pressure of rats. Biological & pharmaceutical bulletin 2001, 24: 1137-1141. 10.1248/bpb.24.1137
Shen ZF, Xie MZ: Measure berberine in bio-samples by HPLC. Yaoxie Xiebao 1993,28(7):532-536.
An S, Wang WB: Study on absorption, distribution and elimination of berberine. Beijing Zhongyi Xieyuan Xiebao (Beijing TCM university newsletter) 1983, 2: 13-15.
Pau LH, Lee PS, Yang PF, Wang HZ, Tche SM, Wu SH, Lee WH: Research on Efficacy of oral medication of "huáng lián sù"(berberine). Chinese Pharmacological Bulletin 1997,13(1):95.
Lau PW, Tsang CM, Tong Y, Tsao SW, Feng Y: The anti-cancer effect and the possible mechanism of berberine [abstract]. In 7th Meeting of Consortium for Globalization of Chinese Medicine (CGCM). Program & Abstracts, Taipei; 2008:84.
Feng Y, Ye XS, Tong Y, Tsao SW: Antioxidative and hepatoprotective effects of coptis extract on liver damage in Rats [abstract]. Progress in biochemistry and biophysics (The XIV Biennial Meeting of the Society for Free Radical Research International, Program & Abstracts), Beijing 2008, 35: 136.